Standout Papers
- Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry (2005)
- Targeting the Cell Cycle: A New Approach to Cancer Therapy (2005)
- Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials (2018)
- Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial (2016)
- Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting (2010)
- Metastatic disease from uveal melanoma: treatment options and future prospects (2016)
Immediate Impact
15 by Nobel laureates 5 from Science/Nature 58 standout
Citing Papers
Metastasis
2023 Standout
CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
Works of Gary K. Schwartz being referenced
PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence
2018
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gary K. Schwartz | 11072 | 8340 | 7272 | 436 | 20.5k | |
| Emile E. Voest | 8345 | 7154 | 3004 | 367 | 18.3k | |
| Grant A. McArthur | 14701 | 14988 | 5248 | 388 | 26.3k | |
| William D. Figg | 9855 | 11342 | 4342 | 599 | 24.6k | |
| Eric K. Rowinsky | 18262 | 11946 | 9456 | 392 | 31.5k | |
| David Cameron | 13235 | 5550 | 4621 | 526 | 23.2k | |
| Herbert I. Hurwitz | 17516 | 7907 | 7651 | 318 | 26.3k | |
| Martin Gore | 14140 | 12791 | 8895 | 377 | 29.0k | |
| Peter J. O’Dwyer | 12800 | 9732 | 5123 | 394 | 23.0k | |
| Martin Schüler | 9451 | 8758 | 7013 | 465 | 19.9k | |
| Patricia LoRusso | 10965 | 10660 | 4274 | 560 | 21.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...